The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
Open accessAbstract
Relative to several other toll-like receptor (TLR) agonists, we found polyinosinic:polycytidylic acid (poly IC) to be the most effective adjuvant for Th1 CD4+ T cell responses to a dendritic cell (DC)–targeted HIV gag protein vaccine in mice. To identify mechanisms for adjuvant action in the intact animal and the polyclonal T cell repertoire, we found poly IC to be the most effective inducer of type I interferon (IFN), which was produced by DEC-205+ DCs, monocytes, and stromal cells. Antibody blocking or deletion of type I IFN receptor showed that IFN was essential for DC maturation and development of CD4+ immunity. The IFN-AR receptor was directly required for DCs to respond to poly IC. STAT 1 was also essential, in keeping with the type I IFN requirement, but not type II IFN or IL-12 p40. Induction of type I IFN was mda5 dependent, but DCs additionally used TLR3. In bone marrow chimeras, radioresistant and, likely, nonhematopoietic cells were the main source of IFN, but mda5 was required in both marrow–derived and radioresistant host cells for adaptive responses. Therefore, the adjuvant action of poly IC requires a widespread innate type I IFN response that directly links antigen presentation by DCs to adaptive immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888 · cited 2×
“helicase MDA5, resulting in activation of IRF-3 and representing a major pathway for the production of type I IFNs in a TLR-independent fashion (Kato et al., 2006).”
BackgroundMethodCloning of a new cytokine that induces IFN-γ production by T cells
Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995) · Nature · doi:10.1038/378088a0 · Cited by 2,600
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Self-citationThe roles of TLRs, RLRs and NLRs in pathogen recognition
Kawai, T., & Akira, S. (2009) · International Immunology · doi:10.1093/intimm/dxp017 · Cited by 1,670
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,602
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H.-W., Park, C. G., et al. (2007) · Science · doi:10.1126/science.1136080 · Cited by 1,455
Self-citationCell Type-Specific Involvement of RIG-I in Antiviral Response
Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K., Tsujimura, T., Takeda, K., Fujita, T., Takeuchi, O., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.010 · Cited by 1,368
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martín-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,353
MACROPHAGE RECEPTORS AND IMMUNE RECOGNITION
Taylor, P. R., Martinez-Pomares, L., Stacey, M., Lin, H.-H., Brown, G. D., & Gordon, S. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115816 · Cited by 1,324
Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021598 · Cited by 1,306
Self-citationInduction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus
Blanco, P., Palucka, A. K., Gill, M., Pascual, V., & Banchereau, J. (2001) · Science · doi:10.1126/science.1064890 · Cited by 1,266
Gitlin, L., Barchet, W., Gilfillan, S., Cella, M., Beutler, B., Flavell, R. A., Diamond, M. S., & Colonna, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603082103 · Cited by 1,169
Self-citationNapolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F., & Lanzavecchia, A. (2005) · Nature Immunology · doi:10.1038/ni1223 · Cited by 1,157
Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo
Tough, D. F., Borrow, P., & Sprent, J. (1996) · Science · doi:10.1126/science.272.5270.1947 · Cited by 1,077
T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells
Afkarian, M., Sedy, J. R., Yang, J., Jacobson, N. G., Cereb, N., Yang, S. Y., Murphy, T. L., & Murphy, K. M. (2002) · Nature Immunology · doi:10.1038/ni794 · Cited by 1,037
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses
Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C.-Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D. A., & Gately, M. K. (1996) · Immunity · doi:10.1016/s1074-7613(00)80413-6 · Cited by 989
Langerhans cells renew in the skin throughout life under steady-state conditions
Merad, M., Manz, M. G., Karsunky, H., Wagers, A., Peters, W., Charo, I., Weissman, I. L., Cyster, J. G., & Engleman, E. G. (2002) · Nature Immunology · doi:10.1038/ni852 · Cited by 977
Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F., & Tough, D. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00126-1 · Cited by 974
Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J., & Murali-Krishna, K. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050821 · Cited by 965
The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4
Mata-Haro, V., Cekic, C., Martin, M., Chilton, P. M., Casella, C. R., & Mitchell, T. C. (2007) · Science · doi:10.1126/science.1138963 · Cited by 896
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon
Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P., & Tough, D. F. (2003) · Nature Immunology · doi:10.1038/ni978 · Cited by 818
T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells
Lighvani, A. A., Frucht, D. M., Jankovic, D., Yamane, H., Aliberti, J., Hissong, B. D., Nguyen, B. V., Gadina, M., Sher, A., Paul, W. E., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261570598 · Cited by 783 · cited 2×
“IL-12 plays a crucial role in Th1 priming (Trinchieri, 1994), whereas IFN- increases responsiveness to IL-12 and, in addition, activates the Th1-specific transcription factor T-bet (Lighvani et al., 2001; Afkarian et al., 2002).”
BackgroundYoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S., Okamura, H., Akira, S., & Nakanishi, K. (1998) · PubMed · Cited by 770
Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 Cells
Rogge, L., Barberis-Maino, L., Biffi, M., Passini, N., Presky, D. H., Gubler, U., & Sinigaglia, F. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.825 · Cited by 766
Type I Interferons Keep Activated T Cells Alive
Marrack, P., Kappler, J., & Mitchell, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.521 · Cited by 759
Gazzinelli, R. T., Wysocka, M., Hayashi, S., Denkers, E. Y., Hieny, S., Caspar, P., Trinchieri, G., & Sher, A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.6.2533 · Cited by 729
Cooper, A. M., Magram, J., Ferrante, J., & Orme, I. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.39 · Cited by 715
Fujii, S.-I., Shimizu, K., Smith, C., Bonifaz, L., & Steinman, R. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030324 · Cited by 711
Self-citationCutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP3
Li, H., Willingham, S. B., Ting, J. P.-Y., & Re, F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.17 · Cited by 675
Yoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S.-I., Okamura, H., Akira, S., & Nakanishi, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3400 · Cited by 675
Fehniger, T. A., Shah, M. H., Turner, M. J., VanDeusen, J. B., Whitman, S. P., Cooper, M. A., Suzuki, K., Wechser, M., Goodsaid, F., & Caligiuri, M. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4511 · Cited by 652
Santini, S. M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T., & Belardelli, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1777 · Cited by 643
Natural-killer cells and dendritic cells: “l'union fait la force”
Walzer, T., Dalod, M., Robbins, S. H., Zitvogel, L., & Vivier, E. (2005) · Blood · doi:10.1182/blood-2005-03-1154 · Cited by 634
Spörri, R., & Reis e Sousa, C. (2005) · Nature Immunology · doi:10.1038/ni1162 · Cited by 626
Translating Innate Immunity into Immunological Memory: Implications for Vaccine Development
Pulendran, B., & Ahmed, R. (2006) · Cell · doi:10.1016/j.cell.2006.02.019 · Cited by 625
Type I IFNs Enhance the Terminal Differentiation of Dendritic Cells
Luft, T., Pang, K. C., Thomas, E., Hertzog, P., Hart, D. N. J., Trapani, J., & Cebon, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1947 · Cited by 611
Type I interferons produced by dendritic cells promote their phenotypic and functional activation
Montoya, M., Schiavoni, G., Mattei, F., Gresser, I., Belardelli, F., Borrow, P., & Tough, D. F. (2002) · Blood · doi:10.1182/blood.v99.9.3263 · Cited by 534
Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells.
Brinkmann, V, Geiger, T., Alkan, S., & Heusser, C. H. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1655 · Cited by 506
In vivo natural killer cell activities revealed by natural killer cell-deficient mice
Kim, S., Iizuka, K., Aguila, H. L., Weissman, I. L., & Yokoyama, W. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050588297 · Cited by 424
CD8+CD205+ Splenic Dendritic Cells Are Specialized to Induce Foxp3+ Regulatory T Cells
Yamazaki, S., Dudziak, D., Heidkamp, G. F., Fiorese, C., Bonito, A. J., Inaba, K., Nussenzweig, M. C., & Steinman, R. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.6923 · Cited by 418
Self-citationVitale, M., Chiesa, M. D., Carlomagno, S., Pende, D., Aricò, M., Moretta, L., & Moretta, A. (2005) · Blood · doi:10.1182/blood-2004-10-4035 · Cited by 414
Alveolar Macrophages Are the Primary Interferon-α Producer in Pulmonary Infection with RNA Viruses
Kumagai, Y., Takeuchi, O., Kato, H., Kumar, H., Matsui, K., Morii, E., Aozasa, K., Kawai, T., & Akira, S. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.013 · Cited by 394
Vaccine manufacturing: challenges and solutions
Ulmer, J. B., Valley, U., & Rappuoli, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1261 · Cited by 376
Honda, K., Sakaguchi, S., Nakajima, C., Watanabe, A., Yanai, H., Matsumoto, M., Ohteki, T., Kaisho, T., Takaoka, A., Akira, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934678100 · Cited by 361
Type I interferon dependence of plasmacytoid dendritic cell activation and migration
Asselin-Paturel, C., Brizard, G., Chemin, K., Boonstra, A., O'Garra, A., Vicari, A., & Trinchieri, G. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041930 · Cited by 343
Differential Regulation of Human Blood Dendritic Cell Subsets by IFNs
Ito, T., Amakawa, R., Inaba, M., Ikehara, S., Inaba, K., & Fukuhara, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.2961 · Cited by 313
Trumpfheller, C., Caskey, M., Nchinda, G., Longhi, M. P., Mizenina, O., Huang, Y., Schlesinger, S. J., Colonna, M., & Steinman, R. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711976105 · Cited by 310
Self-citationRoles of IFN-γ and IFN-α in IL-12-induced T helper cell-1 development
Wenner, C. A., Güler, M. L., Macatonia, S. E., O’Garra, A., & Murphy, K. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.4.1442 · Cited by 305
Loré, K., Betts, M. R., Brenchley, J. M., Kuruppu, J., Khojasteh, S., Perfetto, S., Roederer, M., Seder, R. A., & Koup, R. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4320 · Cited by 291
Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming
Le Bon, A., Durand, V., Kamphuis, E., Thompson, C., Bulfone-Paus, S., Rossmann, C., Kalinke, U., & Tough, D. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4682 · Cited by 283
Verdijk, R. M., Mutis, T., Esendam, B., Kamp, J., Melief, C. J. M., Brand, A., & Goulmy, E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.57 · Cited by 273
Paquette, R. L., Hsu, N. C., Kiertscher, S. M., Park, A. N., Tran, L., Roth, M. D., & Glaspy, J. A. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.358 · Cited by 262
Parlato, S., Santini, S. M., Lapenta, C., Di Pucchio, T., Logozzi, M., Spada, M., Giammarioli, A. M., Malorni, W., Fais, S., & Belardelli, F. (2001) · Blood · doi:10.1182/blood.v98.10.3022 · Cited by 260
Antigen presentation by monocytes and monocyte-derived cells
Randolph, G. J., Jakubzick, C., & Qu, C. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.10.010 · Cited by 237
Controlling the Toll road to dendritic cell polarization
Mazzoni, A., & Segal, D. M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003482 · Cited by 226
Havenar-Daughton, C., Kolumam, G. A., & Murali-Krishna, K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3315 · Cited by 211
Devulder, B. (1994) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(05)82117-4 · Cited by 208
Stahl-Hennig, C., Eisenblätter, M., Jasny, E., Rzehak, T., Tenner-Racz, K., Trumpfheller, C., Salazar, A. M., Überla, K., Nieto, K., Kleinschmidt, J., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000373 · Cited by 198
Self-citationRobinson, R. A., DeVita, V. T., Levy, H. B., Baron, S., Hubbard, S. P., & Levine, A. S. (1976) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/57.3.599 · Cited by 189
Matikainen, S., Paananen, A., Miettinen, M., Kurimoto, M., Timonen, T. T., Julkunen, I., & Sareneva, T. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200107)31:7<2236::aid-immu2236>3.0.co;2-g · Cited by 182
Studies on the production, mode of action and properties of interferon.
Lindenmann, J.-M., Burke, D. C., & Isaacs, A. (1957) · PubMed · Cited by 169
Antigenic Targeting of the Human Mannose Receptor Induces Tumor Immunity
He, L.-Z., Crocker, A., Lee, J., Mendoza-Ramírez, J.-L., Wang, X.-T., Vitale, L. A., O’Neill, T. J., Petromilli, C., Zhang, H., Lopez, J., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6259 · Cited by 167
Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells
Blasius, A. L., Barchet, W., Cella, M., & Colonna, M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070991 · Cited by 166
Self-citationLópez, C. B., Moltedo, B., Alexopoulou, L., Bonifaz, L. C., Flavell, R. A., & Moran, T. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6882 · Cited by 160
The low-toxicity versions of LPS, MPL® adjuvant and RC529, are efficient adjuvants for CD4+ T cells
Thompson, B. S., Chilton, P. M., Ward, J. R., Evans, J. T., & Mitchell, T. C. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0305172 · Cited by 154
Lauzon, N. M., Mian, F., Mackenzie, R., & Ashkar, A. A. (2006) · Cellular Immunology · doi:10.1016/j.cellimm.2006.08.004 · Cited by 151
Mice Lacking IL-12 Develop Polarized Th1 Cells During Viral Infection
Schijns, V. E. C. J., Haagmans, B. L., Wierda, C. M. H., Kruithof, B. P. T., Heijnen, I., Alber, G., & Horzinek, M. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3958 · Cited by 145
IL-12 Is Not Required for Induction of Type 1 Cytokine Responses in Viral Infections
Oxenius, A., Karrer, U., Zinkernagel, R. M., & Hengartner, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.965 · Cited by 140
Kwissa, M., Kasturi, S. P., & Pulendran, B. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.673 · Cited by 117
Salem, M. L., El-Naggar, S. A., Kadima, A. N., Gillanders, W. E., & Cole, D. J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.010 · Cited by 116
Monophosphoryl lipid A (MPL®)* promotes allergen‐induced immune deviation in favour of Th1 responses
Puggioni, F., Durham, S. R., & Francis, J. N. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00762.x · Cited by 107
[Immunizing property of vaccinia virus inactivated by ultraviolets rays].
Nagano, Y., & KOJIMA, Y. (1954) · PubMed · Cited by 98
Sawaki, J., Tsutsui, H., Hayashi, N., Yasuda, K., Akira, S., Tanizawa, T., & Nakanishi, K. (2007) · International Immunology · doi:10.1093/intimm/dxl148 · Cited by 91
Nolte, M. A., LeibundGut‐Landmann, S., Joffre, O. P., & Sousa, C. R. E. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070325 · Cited by 63
IFN-α Is Not Sufficient to Drive Th1 Development Due to Lack of Stable T-bet Expression
Ramos, H. J., Davis, A. M., George, T. C., & Farrar, J. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3792 · Cited by 52
De novo production of antigen-specific suppressor cells in vivo
Kretschmer, K., Heng, T. S. P., & von Boehmer, H. (2006) · Nature Protocols · doi:10.1038/nprot.2006.105 · Cited by 45
Pouvoir immunisant du virus vaccinal inactive par des rayons ultraviolets
Nagano, T. (1954) · Medical Entomology and Zoology · Cited by 43
Berenson, L. S., Farrar, J. D., Murphy, T. L., & MURPHY, K. M. M. (2004) · European Journal of Immunology · doi:10.1002/eji.200324829 · Cited by 33
Tsujimoto, H., Efron, P. A., Matsumoto, T., Ungaro, R. F., Abouhamze, A. S., Ono, S., Mochizuki, H., & Moldawer, L. L. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.09.001 · Cited by 27
Chakir, H., Lemay, A., & Webb, J. R. (2001) · Cellular Immunology · doi:10.1006/cimm.2001.1844 · Cited by 26
Seder, R. A., & Mascola, J. R. (2003) · Elsevier eBooks · doi:10.1016/b978-012107258-2/50006-8 · Cited by 14
Cited by
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658
“Furthermore, the recognition of poly(I:C) by MDA5 expressed by DCs, monocytes, and stromal cells and the induction of type I IFN are required to support Th1 cell responses (Longhi et al., 2009).”
BackgroundPathogen Recognition by the Innate Immune System
Kumar, H., Kawai, T., & Akira, S. (2011) · International Reviews of Immunology · doi:10.3109/08830185.2010.529976 · Cited by 2,257
Regulation of Adaptive Immunity by the Innate Immune System
Iwasaki, A., & Medzhitov, R. (2010) · Science · doi:10.1126/science.1183021 · Cited by 2,157
Vaccine Adjuvants: Putting Innate Immunity to Work
Coffman, R. L., Sher, A., & Seder, R. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.002 · Cited by 1,924
Metadata
- Authors
- Longhi, M. P., Trumpfheller, C., Idoyaga, J., Caskey, M., Matos, I., Kluger, C., Salazar, A. M., Colonna, M., & Steinman, R. M.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2009-06-29
- Volume
- 206
- Issue
- 7
- Pages
- 1589-1602
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2156313733
- Cited by
- 663
- References
- 85
- FWCI
- 24.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.